Reshma Kewalramani, CEO & President: Vertex Pharmaceuticals VRTX Sell · Filed 03/03

Trade details

Type: Insider sale
Amount: $1,243,090.8
Shares · price: 2,520 sh · $493.29 a share
Held after: 125,076 sh
Stock: Vertex Pharmaceuticals VRTX
Person: Reshma KewalramaniCEO & President
Trade date: 26/02/27
Filed: 26/03/03
Days to filing: 4 days

Sold 2.0% of holdings

Share of holding sold: 2.0%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 01/28~03/29

Reshma Kewalramani's recent trades

Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$7.7M
15,580 sh
$7.7M
Filed 03/03
Traded 02/27
Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$3M
5,995 sh
$3M
Filed 03/03
Traded 02/27
Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.7M
3,498 sh
$1.7M
Filed 03/03
Traded 02/27
Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.6M
3,278 sh
$1.6M
Filed 03/03
Traded 02/27
Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.3M
2,725 sh
$1.3M
Filed 03/03
Traded 02/27

Reshma Kewalramani, CEO — sold $1.2M of Vertex Pharmaceuticals VRTX · 2.0% of holdings · 10b5-1 plan | Whalegun